参考文献/References:
[1] Zomer AC,Uiterwaal CS,van der Velde ET,et al. Mortality in adult congenital heart disease:are national registries reliable for cause of death?[J]. Int J Cardiol,2011,152(2):212-217.
[2] Kiran U,Aggarwal S,Choudhary A,et al. The blalock and taussig shunt revisited[J]. Ann Card Anaesth,2017,20(3):323-330.
[3] Delhaas T,Koeken Y,Latus H,et al. Potts shunt to be preferred above atrial septostomy in pediatric pulmonary arterial hypertension patients:a modeling study[J]. Front Physiol,2018,9:1252.
[4] Blanc J,Vouhé P,Bonnet D. Potts shunt in patients with pulmonary hypertension[J]. N Engl J Med,2004,350(6):623.
[5] Stenmark KR,Meyrick B,Galie N,et al. Animal models of pulmonary arterial hypertension:the hope for etiological discovery and pharmacological cure[J]. Am J Physiol Lung Cell Mol Physiol,2009,297(6):L1013-L1032.
[6] Maarman G,Lecour S,Butrous G,et al. A comprehensive review:the evolution of animal models in pulmonary hypertension research;are we there yet?[J]. Pulm Circ,2013,3(4):739-756.
[7] Sztuka K,Jasińska-Stroschein M. Animal models of pulmonary arterial hypertension:a systematic review and meta-analysis of data from 6 126 animals[J]. Pharmacol Res,2017,125(Pt B):201-214.
[8] Dickinson MG,Bartelds B, Borgdorff MA,et al. The role of disturbed blood flow in the development of pulmonary arterial hypertension:lessons from preclinical animal models[J]. Am J Physiol Lung Cell Mol Physiol,2013,305(1):L1-L14.
[9] Colvin KL,Yeager ME. Animal models of pulmonary hypertension:matching disease mechanisms to etiology of the human disease[J]. J Pulm Respir Med,2014,4(4):198.
[10]Johnson Kameny R,Datar SA,Boehme JB,et al. Ovine models of congenital heart disease and the consequences of hemodynamic alterations for pulmonary artery remodeling[J]. Am J Respir Cell Mol Biol,2019,60(5):503-514.
[11]Heath D,Donald DE,Edwards JE. Pulmonary vascular changes in a dog after aortopulmonary anastomosis for four years[J]. Br Heart J,1959,21(2):187-196.
[12]Schnader J,Schloo BL,Anderson W,et al. Chronic pulmonary hypertension in sheep:temporal progression of lesions[J]. J Surg Res,1996,62(2):243-250.
[13]Bousamra M 2nd,Rossi R,Jacobs E,et al. Systemic lobar shunting induces advanced pulmonary vasculopathy[J]. J Thorac Cardiovasc Surg,2000,120(1):88-98.
[14]Rondelet B,Dewachter C,Kerbaul F,et al. Prolonged overcirculation-induced pulmonary arterial hypertension as a cause of right ventricular failure[J]. Eur Heart J,2012,33(8):1017-1026.
[15]Rondelet B,Dewachter L,Kerbaul F,et al. Sildenafil added to sitaxsentan in overcirculation-induced pulmonary arterial hypertension[J]. Am J Physiol Heart Circ Physiol,2010,299(4):H1118-H1123.
[16]Rothman A,Wiencek RG,Davidson S,et al. Challenges in the development of chronic pulmonary hypertension models in large animals[J]. Pulm Circ,2017,7(1):156-166.
[17]van Albada ME,Schoemaker RG,Kemna MS,et al. The role of increased pulmonary blood flow in pulmonary arterial hypertension[J]. Eur Respir J,2005,26(3):487-493.
[18]Gomez-Arroyo J,Saleem SJ,Mizuno S,et al. A brief overview of mouse models of pulmonary arterial hypertension:problems and prospects[J]. Am J Physiol Lung Cell Mol Physiol,2012,302(10):L977-L991.
[19]Boudjemline Y,Sizarov A,Malekzadeh-Milani S,et al. Safety and feasibility of the transcatheter approach to create a reverse Potts shunt in children with idiopathic pulmonary arterial hypertension[J]. Can J Cardiol,2017,33(9):1188-1196.
[20]Vitanova K,Leopold C,von Ohain JP,et al. Reasons for failure of systemic-to-pulmonary artery shunts in neonates[J]. Thorac Cardiovasc Surg,2019,67(1):2-7.
[21]张明杰. 先心病肺动脉高压生物标记物筛选和动物模型构建[D]. 上海交通大学,2013.
[22]Maschietto N,Baird C,Porras D. Percutaneous intraluminal downsizing of systemic-to-pulmonary artery shunts:a novel application of the Diabolo stent technique-Case series and description of the technique[J]. Catheter Cardiovasc Interv,2020,95(3):471-476.
[23]Esch JJ,Shah PB,Cockrill BA,et al. Transcatheter Potts shunt creation in patients with severe pulmonary arterial hypertension:initial clinical experience[J]. J Heart Lung Transplant,2013,32(4):381-387.
[24]Sizarov A,Raimondi F,Bonnet D,et al. Vascular anatomy in children with pulmonary hypertension regarding the transcatheter Potts shunt[J]. Heart,2016,102(21):1735-1741.
[25]Tanase D,Georgiev S,Eicken A,et al. Transcatheter creation of bidirectional cavopulmonary connections by needle punctures in two patients[J]. Catheter Cardiovasc Interv,2020,95(7):1305-1309.
[26]Levi DS,Danon S,Gordon B,et al. Creation of transcatheter aortopulmonary and cavopulmonary shunts using magnetic catheters:feasibility study in swine[J]. Pediatr Cardiol,2009,30(4):397-403.
[27]Sabi TM,Schmitt B,Sigler M,et al. Transcatheter creation of an aortopulmonary shunt in an animal model[J]. Catheter Cardiovasc Interv,2010,75(4):563-569.
[28]Schmitt B,Sabi TM,Sigler M,et al. Upper cavo-pulmonary anastomosis by transcatheter technique[J]. Catheter Cardiovasc Interv,2012,80(1):93-99.
[29]Ratnayaka K,Rogers T,Schenke WH,et al. Magnetic resonance imaging-guided transcatheter cavopulmonary shunt[J]. JACC Cardiovasc Interv,2016,9(9):959-970.
[30]Sayadpour Zanjani K. Radiofrequency perforation may increase the safety of transcatheter Potts shunt creation[J]. J Heart Lung Transplant,2013,32(9):938.
[31]Aggarwal V,Dhillon GS,Penny DJ,et al. Drug-eluting stents compared with bare metal stents for stenting the ductus arteriosus in infants with ductal-dependent pulmonary blood flow[J]. Am J Cardiol,2019,124(6):952-959.
[32]Sizarov A,Raimondi F,Bonnet D,et al. Vascular anatomy in children with univentricular hearts regarding transcatheter bidirectional Glenn anastomosis[J]. Arch Cardiovasc Dis,2017,110(4):223-233.
[33]Alexy RD,Levi DS. Materials and manufacturing technologies available for production of a pediatric bioabsorbable stent[J]. Biomed Res Int,2013,2013:137985.
[34]杨广鑫,栾景源. 生物可降解金属血管支架研究进展[J]. 中国微创外科杂志,2018,18(8) :753-757,760.
相似文献/References:
[1]郭琳娟,洪葵.成人先天性心脏病心律失常的诊断和治疗进展[J].心血管病学进展,2015,(6):752.[doi:10.3969/j.issn.1004-3934.2015.06.024]
GUO Linjuan,HONG Kui.Advances in Diagnosis and Treatment of Adult Congenital Heart
Disease with Arrhythmia[J].Advances in Cardiovascular Diseases,2015,(7):752.[doi:10.3969/j.issn.1004-3934.2015.06.024]
[2]朱峰,陈铀.先天性心脏病相关肺动脉高压的治疗进展[J].心血管病学进展,2019,(6):894.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.014]
ZHU Feng,CHEN You.Congenital Heart Disease-related Pulmonary Arterial Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):894.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.014]
[3]黄金秋 路发文 赵永康 陈宇雨 史红蕊 王萍 杨菊仙.先天性心脏病患儿营养状况及其危险因素分析[J].心血管病学进展,2020,(12):1324.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.023]
HUANG Jinqiu,LU Fawen,ZHAO Yongkang,et al.Nutritional Status in Children with Congenital Heart Disease and the Influential Factors[J].Advances in Cardiovascular Diseases,2020,(7):1324.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.023]
[4]林锡祥 杨菲菲 陈煦 何昆仑.人工智能赋能医学影像在先天性心脏病医学诊治中的研究进展[J].心血管病学进展,2022,(12):1063.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.002]
LIN Xixiang,YANG Feifei,CHEN Xu,et al.Artificial Intelligence Medical Imaging Technology in Medical Imaging of Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2022,(7):1063.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.002]
[5]刘晓旭 莫绪明.先天性心脏病患儿心肺转流术后肠道损伤机制及治疗进展[J].心血管病学进展,2023,(6):501.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.0005]
LIU Xiaoxu,MO Xuming.Mechanism and Treatment of Intestinal Injury After Cardiopulmonary Bypass in Children with Congenital Heart Disease[J].Advances in Cardiovascular Diseases,2023,(7):501.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.0005]
[6]董捷 杜楚豪 董硕 刘顺 徐海涛 孙阳雪 邹孟轩 孙家树 李守军 杨克明 闫军.Uhl畸形诊断与治疗研究进展[J].心血管病学进展,2023,(8):686.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.004]
DONG Jie DU Chuhao DONG ShuoLIU Shun,XU HaitaoSUN YangxueZOU MengxuanSUN JiashuLI Shoujun,YANG Keming,et al.Diagnosis and Treatment for Uhls Anomaly[J].Advances in Cardiovascular Diseases,2023,(7):686.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.004]
[7]陈颖慧 冯奕源 冯炜琦 吴逸卓 鲁亚南 于昱.血管发育异常的先天性心脏病患儿中Vav2基因突变的筛查和功能分析[J].心血管病学进展,2023,(8):757.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.019]
CHEN Yinghui,FENG Yiyuan,FENG Weiqi,et al.Identification and Functional Analysis of Vav2 Novel Variant in Congenital Heart Diseases with Vascular Malformation[J].Advances in Cardiovascular Diseases,2023,(7):757.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.019]
[8]李强强 顾虹.中国儿童肺动脉高压诊治现状[J].心血管病学进展,2024,(1):7.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.003]
LI Qiangqiang,GU Hong.Current Status of Diagnosis and Treatment of Pulmonary Hypertension in Chinese Children[J].Advances in Cardiovascular Diseases,2024,(7):7.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.003]
[9]李思聪 罗勤 赵智慧 赵青 柳志红.房间隔缺损相关肺动脉高压机制及治疗进展[J].心血管病学进展,2024,(1):11.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.004]
LI Sicong,LUO Qin,ZHAO Zhihui,et al.Pathogenesis and Treatment of Pulmonary Hypertension Associated with Atrial Septal Defect[J].Advances in Cardiovascular Diseases,2024,(7):11.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.004]
[10]关璐茜 罗勤 胡海波.高原地区先天性心脏病相关性肺动脉高压的研究进展[J].心血管病学进展,2024,(1):15.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.005]
GUAN Luxi,LUO Qin,HU Haibo.Pulmonary Arterial Hypertension Associated with Congenital Heart Disease at High Altitude[J].Advances in Cardiovascular Diseases,2024,(7):15.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.005]